PRESS RELEASE published on 03/12/2025 at 07:28, 1 year 3 months ago Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins Ipsen appoints Olivia Brown as EVP, Global Head of Neurotoxins, leading strategic growth in therapeutic and aesthetic neurotoxins market. Olivia brings 20 years of pharmaceutical and aesthetics leadership experience Innovation Ipsen Global Head Neurotoxins Olivia Brown
PRESS RELEASE published on 02/21/2025 at 15:42, 1 year 4 months ago Ipsen S.A. publishes its 2024 consolidated financial statements
BRIEF published on 09/23/2024 at 11:01, 1 year 9 months ago Parvus Asset Management crosses threshold in IPSEN SA Euronext Paris Voting Rights Threshold Crossing Ipsen SA Parvus Asset Management
BRIEF published on 09/16/2024 at 14:50, 1 year 9 months ago Promising results for Cabometyx in advanced neuroendocrine tumors Phase III Ipsen Neuroendocrine Tumors ESMO 2024 Cabometyx
PRESS RELEASE published on 09/16/2024 at 14:45, 1 year 9 months ago Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors Final results from CABINET Phase III trial show significant reduction in disease progression or death risk with Cabometyx in advanced neuroendocrine tumors. Data presented at ESMO 2024 and NEJM Phase III Trial Neuroendocrine Tumors ESMO 2024 Cabometyx Disease Progression
BRIEF published on 09/15/2024 at 14:50, 1 year 9 months ago New analysis of the CONTACT-02 trial by Ipsen Clinical Trial Ipsen Prostate Cancer CONTACT-02 Cabometyx
PRESS RELEASE published on 08/13/2024 at 18:00, 1 year 10 months ago IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024
BRIEF published on 05/28/2024 at 07:05, 2 years ago Ipsen Proposes Share Repurchase Program at Annual General Meeting Annual General Meeting French Commercial Code Share Repurchase Stock Buyback Ipsen
BRIEF published on 05/28/2024 at 07:05, 2 years ago Ipsen Announces Share Repurchase Program Details Annual General Meeting Share Repurchase Corporate Governance Investment Stock Buyback
PRESS RELEASE published on 05/28/2024 at 07:00, 2 years ago Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024 Ipsen S.A. presents the regulatory framework of the share repurchase program proposed at the Annual General Meeting on 28 May 2024, covering objectives, characteristics, maximum repurchase amount, price, and duration Annual General Meeting Share Repurchase Program Regulatory Framework Ipsen S.A. Maximum Repurchase Price
Published on 06/24/2026 at 23:05, 33 minutes ago Polaris Modifies Quorum Requirement for Upcoming AGM
Published on 06/24/2026 at 22:15, 1 hour 23 minutes ago Organto Foods Announces Annual General Meeting Results
Published on 06/24/2026 at 21:20, 2 hours 18 minutes ago Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/24/2026 at 20:10, 3 hours 28 minutes ago Fox River Obtains Final Order Approving Plan of Arrangement With Avenir Minerals Limited
Published on 06/24/2026 at 20:54, 2 hours 43 minutes ago EQS-Adhoc: Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/24/2026 at 18:25, 5 hours 13 minutes ago Huawei Helps Global Carriers Monetize Tokens with Service-Network-Compute Integration
Published on 06/24/2026 at 18:25, 5 hours 13 minutes ago Annual General Meeting of Highlight Event and Entertainment AG
Published on 06/24/2026 at 18:05, 5 hours 33 minutes ago BOS GmbH & Co. KG: Admission of bonds to trading on the Luxembourg Stock Exchange
Published on 06/24/2026 at 17:45, 5 hours 53 minutes ago Air Liquide continues its long-term growth in Kazakhstan with a key investment to support Silleno's world-scale plant
Published on 06/24/2026 at 17:40, 5 hours 58 minutes ago Report on share repurchases from 17 to 23 June 2026
Published on 06/24/2026 at 16:21, 7 hours 17 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of May 31, 2026